TY  - CHAP
M1  - Book, Section
TI  - Goodman & Gilman Year in Review Biologics FDA Approvals
A1  - Murri, PharmD, MBA, Nelda
A2  - Brunton, Laurence L.
A2  - Hilal-Dandan, Randa
A2  - Knollmann, Björn C.
Y1  - 2017
N1  - 
T2  - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e
AB  - In  2017  the  U.S.  Food  and  Drug  Administration  (FDA)  approved  40  new  drugs  and  granted  48  noteworthy  biologic  licenses.  The  40  new  drugs  are  cataloged  in  Part  1.  Among  them  are:  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - hemonc.mhmedical.com/content.aspx?aid=1164576164
ER  -